A Prediction Model and Assisted Decision-making System of Fertilization Disorders

Sponsor
Peking University Third Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05730764
Collaborator
(none)
260
2
9.1

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to test the accuracy of the forecasting system we develop.

The main question it aims to answer is:
  • Whether the clinical prediction system predicts the incidence of fertilization disorders accurately.

  • The fertilization disorder prediction system predicts whether and how much the outcome differs from the doctor.

Participants will receive treatment assisted by a predictive system or receive general treatment.

Researchers will compare incidence of fertilization disorders to see if the fertilization disorder prediction system makes correct predictions.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Accurate prediction of fertilization disorders and clinical decision support systems assist doctors in decision-making
  • Diagnostic Test: Clinicians follow a routine protocol
N/A

Detailed Description

Through the design method of single-center randomized controlled trial, 260 infertility patients were recruited, and they were divided into two groups of 130 cases in each group according to the method of block randomization, one of which was the intervention group, with the help of accurate prediction of fertilization disorders and clinical decision support systems, clinicians predicted and judged the probability and key factors of fertilization disorders of patients, and formulated and implemented personalized diagnosis and treatment plans based on the prediction results; The other group is the control group, which is treated by clinicians according to the conventional diagnosis and treatment plan, and the system performs parallel simulation operation to predict the outcome of fertilization disorders in patients without affecting any diagnosis and treatment decisions of clinicians. Through the comparison of the two groups, the predictive ability of the system for fertilization disorders was evaluated, and the effectiveness and safety of the personalized diagnosis and treatment plan formulated with the assistance of the system were observed, the primary observation outcomes were the incidence of fertilization disorders, and the secondary observation outcomes were embryo transfer rate, biochemical pregnancy rate, clinical pregnancy rate, etc.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
260 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
A Prediction Model and Assisted Decision-making System of Fertilization Disorders: a Single-center Randomized Controlled Trial
Anticipated Study Start Date :
Feb 28, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Support systems assist doctors in decision-making

Doctors judge the risk of fertilization disorders and make clinical decisions with the support of a decision-making system.

Diagnostic Test: Accurate prediction of fertilization disorders and clinical decision support systems assist doctors in decision-making
With the assistance of accurate prediction of fertilization disorders and clinical decision support systems, clinicians predict and judge the probability and key factors of fertilization disorders of patients, and formulate and implement personalized diagnosis and treatment plans based on the prediction results

Other: Clinicians follow a routine protocol

Doctors judge the risk of fertilization disorders and make clinical decisions based on clinical experience

Diagnostic Test: Clinicians follow a routine protocol
Treatment is performed by the clinician according to the usual protocol.

Outcome Measures

Primary Outcome Measures

  1. Incidence of fertilization disorders [through study completion, an average of 3 months]

    Occurrence of fertilization disorders in participants

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. infertile couples

  2. have indications for acceptance of IVF or ICSI

  3. Both parties sign an informed consent form and can complete the follow-up visit

Exclusion Criteria:
  1. At least one of the spouses has contraindics to IVF or ICSI

  2. Major diseases

  3. Fresh cycle, PGT, IVM

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT05730764
Other Study ID Numbers:
  • IRB00006761-M2022487
First Posted:
Feb 16, 2023
Last Update Posted:
Feb 16, 2023
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2023